Clinical Trial Update: VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) [Phase 3]

View source ↗

Summary

VK2735 is being studied in a Phase 3 trial (VANQUISH 2) for weight management in adults with type 2 diabetes, and the trial is currently active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• VK2735

Snippet

Sponsor: Viking Therapeutics, Inc. | Conditions: Weight Loss | Phase 3 | Status: ACTIVE_NOT_RECRUITING